Sublingual film containing BXCL501 (Dexmedetomidine)
BXCL501-102
Phase 1 small_molecule completed
Quick answer
Sublingual film containing BXCL501 (Dexmedetomidine) for Agitation is a Phase 1 program (small_molecule) at BioXcel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioXcel Therapeutics
- Indication
- Agitation
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed